BIO Comments on Court Injunction Blocking Federal Funding of Embryonic Stem Cell Research

  • Contact: Contact Jeff Joseph, Stephanie Fischer
    202-962-9230, 202-312-9263
  • Recommend
  • Tweet
  • Print
  • Email

WASHINGTON, D.C. (Tuesday, August 24, 2010) - Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement today regarding the injunction issued yesterday by a U.S. District Court prohibiting the use of federal funds to support embryonic stem cell research:

"The preliminary injunction issued yesterday by the U.S. District Court blocking federal funding of embryonic stem cell (ESC) research casts a dark cloud of uncertainty, for the moment, on promising ESC research. For more than a decade, ESC research consistently has demonstrated that it holds great hope for the development of breakthrough treatments and cures for debilitating diseases such as Alzheimer’s, spinal cord injuries, diabetes and more.

"Each day we wait for the judicial process to play out is a day lost for patients and their families living with such diseases.

"We already have seen the promising possibility of stem cell research with companies like Geron showing astonishing results in the area of spinal cord injuries. As we have previously said, researchers should pursue all areas of stem cell research in the search for new therapies and cures.

"We hope the judicial process moves quickly to clear this uncertainty to permit federally funded ESC research to move forward again. Millions of patients are waiting."

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.